Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia.

Literature DB >> 26250575

Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia.

Elisa Rumi¹, Irene Bertozzi², Ilaria C Casetti³, Elisa Roncoroni⁴, Chiara Cavalloni³, Marta Bellini³, Emanuela Sant'Antonio³, Manuel Gotti⁴, Virginia V Ferretti⁴, Chiara Milanesi⁴, Edoardo Peroni², Daniela Pietra⁴, Cesare Astori⁴, Maria Luigia Randi², Mario Cazzola⁵.

Abstract

Entities: Disease Species

Keywords: CALR; JAK2; MPL; essential thrombocythemia; pregnancy

Mesh：

Year: 2015 PMID： 26250575 PMCID： PMC4825313 DOI： 10.3324/haematol.2015.131458

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

12 in total

Review 1. Pregnancy and its management in the Philadelphia negative myeloproliferative diseases.

Authors: Claire Harrison
Journal: Br J Haematol Date: 2005-05 Impact factor: 6.998

2. No evidence for increased prevalence of JAK2 V617F in women with a history of recurrent miscarriage.

Authors: Issa J Dahabreh; Amy V Jones; Michael Voulgarelis; Stavroula Giannouli; Christine Zoi; Christina Alafakis-Tzannatos; Marighoula Varla-Leftherioti; Haralampos M Moutsopoulos; Dimitris Loukopoulos; Stelios Fotiou; Nicholas C P Cross; Katerina Zoi
Journal: Br J Haematol Date: 2008-11-17 Impact factor: 6.998

Review 3. Essential thrombocythemia/polycythemia vera and pregnancy: the need for an observational study in Europe.

Authors: Martin Griesshammer; Sabine Struve; Claire M Harrison
Journal: Semin Thromb Hemost Date: 2006-06 Impact factor: 4.180

4. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).

Authors: Tiziano Barbui; Guido Finazzi; Alessandra Carobbio; Juergen Thiele; Francesco Passamonti; Elisa Rumi; Marco Ruggeri; Francesco Rodeghiero; Maria Luigia Randi; Irene Bertozzi; Heinz Gisslinger; Veronika Buxhofer-Ausch; Valerio De Stefano; Silvia Betti; Alessandro Rambaldi; Alessandro M Vannucchi; Ayalew Tefferi
Journal: Blood Date: 2012-10-01 Impact factor: 22.113

5. Somatic mutations of calreticulin in myeloproliferative neoplasms.

Authors: Thorsten Klampfl; Heinz Gisslinger; Ashot S Harutyunyan; Harini Nivarthi; Elisa Rumi; Jelena D Milosevic; Nicole C C Them; Tiina Berg; Bettina Gisslinger; Daniela Pietra; Doris Chen; Gregory I Vladimer; Klaudia Bagienski; Chiara Milanesi; Ilaria Carola Casetti; Emanuela Sant'Antonio; Virginia Ferretti; Chiara Elena; Fiorella Schischlik; Ciara Cleary; Melanie Six; Martin Schalling; Andreas Schönegger; Christoph Bock; Luca Malcovati; Cristiana Pascutto; Giulio Superti-Furga; Mario Cazzola; Robert Kralovics
Journal: N Engl J Med Date: 2013-12-10 Impact factor: 91.245

6. Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry.

Authors: Lorella Melillo; Alessia Tieghi; Anna Candoni; Franca Radaelli; Rosanna Ciancia; Giorgina Specchia; Bruno Martino; Potito Rosario Scalzulli; Roberto Latagliata; Fausto Palmieri; Emilio Usala; Daniela Valente; Maria Rosa Valvano; Michele Cedrone; Giuseppina Comitini; Vincenzo Martinelli; Nicola Cascavilla; Luigi Gugliotta
Journal: Am J Hematol Date: 2009-10 Impact factor: 10.047

7. Pregnancy complications predict thrombotic events in young women with essential thrombocythemia.

Authors: Maria Luigia Randi; Irene Bertozzi; Elisa Rumi; Chiara Elena; Guido Finazzi; Nicola Vianelli; Nicola Polverelli; Marco Ruggeri; Alessandro Maria Vannucchi; Elisabetta Antonioli; Federico Lussana; Alessia Tieghi; Alessandra Iurlo; Elena Elli; Marco Ruella; Fabrizio Fabris; Mario Cazzola; Tiziano Barbui
Journal: Am J Hematol Date: 2014-02-19 Impact factor: 10.047

8. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation.

Authors: Francesco Passamonti; Maria Luigia Randi; Elisa Rumi; Ester Pungolino; Chiara Elena; Daniela Pietra; Margherita Scapin; Luca Arcaini; Fabiana Tezza; Remigio Moratti; Cristiana Pascutto; Fabrizio Fabris; Enrica Morra; Mario Cazzola; Mario Lazzarino
Journal: Blood Date: 2007-04-10 Impact factor: 22.113

9. Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies.

Authors: Naseema Gangat; Alexandra P Wolanskyj; Susan Schwager; Ayalew Tefferi
Journal: Eur J Haematol Date: 2009-01-06 Impact factor: 2.997

10. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.

Authors: J Nangalia; C E Massie; E J Baxter; F L Nice; G Gundem; D C Wedge; E Avezov; J Li; K Kollmann; D G Kent; A Aziz; A L Godfrey; J Hinton; I Martincorena; P Van Loo; A V Jones; P Guglielmelli; P Tarpey; H P Harding; J D Fitzpatrick; C T Goudie; C A Ortmann; S J Loughran; K Raine; D R Jones; A P Butler; J W Teague; S O'Meara; S McLaren; M Bianchi; Y Silber; D Dimitropoulou; D Bloxham; L Mudie; M Maddison; B Robinson; C Keohane; C Maclean; K Hill; K Orchard; S Tauro; M-Q Du; M Greaves; D Bowen; B J P Huntly; C N Harrison; N C P Cross; D Ron; A M Vannucchi; E Papaemmanuil; P J Campbell; A R Green
Journal: N Engl J Med Date: 2013-12-10 Impact factor: 91.245

5 in total

Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia.

Review 1. Pregnancy and its management in the Philadelphia negative myeloproliferative diseases.

2. No evidence for increased prevalence of JAK2 V617F in women with a history of recurrent miscarriage.

Review 3. Essential thrombocythemia/polycythemia vera and pregnancy: the need for an observational study in Europe.

4. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).

5. Somatic mutations of calreticulin in myeloproliferative neoplasms.

6. Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry.

7. Pregnancy complications predict thrombotic events in young women with essential thrombocythemia.

8. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation.

9. Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies.

10. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.

1. Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series.

Review 2. Treatment options and pregnancy management for patients with PV and ET.

3. Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety.

4. Pregnancy and myeloproliferative neoplasms : A retrospective monocentric cohort.

Review 5. Is there a gender effect in polycythemia vera?